Publications

Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

 80
Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

Tags:

Previous Article

Broadly neutralizing antibodies against emerging delta-coronaviruses

Next Article

Immunotherapy for glioblastoma and its microenvironment

Related Posts

Identification of CCL3 as a Schwann cell chemotactic factor essential for nerve regeneration

Identification of CCL3 as a Schwann cell chemotactic fa...

 84

Analysis of human urinary extracellular vesicles reveals disordered renal metabolism in myotonic dystrophy type 1

Analysis of human urinary extracellular vesicles reveal...

 66

Global organelle profiling reveals subcellular localization and remodeling at proteome scale

Global organelle profiling reveals subcellular localiza...

 45